X-11762903-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_078629.4(MSL3):āc.655A>Gā(p.Ile219Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000827 in 1,209,222 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.0000064 ( 0 hom. 0 hem. )
Consequence
MSL3
NM_078629.4 missense
NM_078629.4 missense
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 8.02
Genes affected
MSL3 (HGNC:7370): (MSL complex subunit 3) This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.26033768).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSL3 | NM_078629.4 | c.655A>G | p.Ile219Val | missense_variant | 7/13 | ENST00000312196.10 | NP_523353.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSL3 | ENST00000312196.10 | c.655A>G | p.Ile219Val | missense_variant | 7/13 | 1 | NM_078629.4 | ENSP00000312244 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112645Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34797
GnomAD3 genomes
AF:
AC:
3
AN:
112645
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34797
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 181365Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65825
GnomAD3 exomes
AF:
AC:
3
AN:
181365
Hom.:
AF XY:
AC XY:
0
AN XY:
65825
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1096577Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 361987
GnomAD4 exome
AF:
AC:
7
AN:
1096577
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
361987
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112645Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34797
GnomAD4 genome
AF:
AC:
3
AN:
112645
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34797
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.655A>G (p.I219V) alteration is located in exon 7 (coding exon 7) of the MSL3 gene. This alteration results from a A to G substitution at nucleotide position 655, causing the isoleucine (I) at amino acid position 219 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T;T;.;.;.;.;.;T;T;.;T;T;T;T;.;.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;.;.;N;.;.;.;.;.;N;N;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Benign
T;T;T;.;.;T;.;.;.;.;.;T;T;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;T;.;.;T;.;.;.;.;.;T;T;.;.;.;.;.;.;.;.;.
Polyphen
0.0050
.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MVP
MPC
0.62
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at